Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

PHARVARIS PHARMACEUTICALS, INC. (FKA PHARVARIS, INC.)

Filed by ARENTFOX SCHIFF LLP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-01 06:26:09 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 19, 2026
Income
$40,000.00
Expenses
Not reported
Filing UUID
22ededbc-dc62-4512-9b8c-590038ca8b8b
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production. H.R.5509 - Safe Step Act, generally

Literal federal measure citations: H.R.5509

MMM · Medicare/Medicaid

Advocacy of policies, legislation and coverage of new pharmaceuticals in the orphan drug space.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.